Jacques Banchereau

Jacques Banchereau is an internationally prominent French American immunologist and molecular biologist. As of 2024, he is Chief Scientific Officer at Javelin Biotech. He was formerly professor and director of immunological sciences at the Jackson Laboratory for Genomic Medicine and also the former chief science officer, senior vice president, and DTA (Discovery and Translational Area) head of inflammation & virology at Hoffman-La Roche. He is best known for his extensive research on dendritic cells with Nobel Laureate Ralph M. Steinman. He is the fifth most cited immunologist ranked by Times Higher Education's report. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Jacques Banchereau', query time: 0.01s Refine Results
  1. 1
    Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.

    Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. by Sonja Tattermusch, Jason A Skinner, Damien Chaussabel, Jacques Banchereau, Matthew P Berry, Finlay W McNab, Anne O'Garra, Graham P Taylor, Charles R M Bangham

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling.

    Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling. by Jonathan M Pitt, Simon Blankley, Krzysztof Potempa, Christine M Graham, Lucia Moreira-Teixeira, Finlay W McNab, Ashleigh Howes, Evangelos Stavropoulos, Virginia Pascual, Jacques Banchereau, Damien Chaussabel, Anne O'Garra

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.

    The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis. by Simon Blankley, Christine M Graham, Jacob Turner, Matthew P R Berry, Chloe I Bloom, Zhaohui Xu, Virginia Pascual, Jacques Banchereau, Damien Chaussabel, Ronan Breen, George Santis, Derek M Blankenship, Marc Lipman, Anne O'Garra

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.

    Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. by Chloe I Bloom, Christine M Graham, Matthew P R Berry, Katalin A Wilkinson, Tolu Oni, Fotini Rozakeas, Zhaohui Xu, Jose Rossello-Urgell, Damien Chaussabel, Jacques Banchereau, Virginia Pascual, Marc Lipman, Robert J Wilkinson, Anne O'Garra

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.

    Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. by Chloe I Bloom, Christine M Graham, Matthew P R Berry, Fotini Rozakeas, Paul S Redford, Yuanyuan Wang, Zhaohui Xu, Katalin A Wilkinson, Robert J Wilkinson, Yvonne Kendrick, Gilles Devouassoux, Tristan Ferry, Makoto Miyara, Diane Bouvry, Dominique Valeyre, Guy Gorochov, Derek Blankenship, Mitra Saadatian, Phillip Vanhems, Huw Beynon, Rama Vancheeswaran, Melissa Wickremasinghe, Damien Chaussabel, Jacques Banchereau, Virginia Pascual, Ling-Pei Ho, Marc Lipman, Anne O'Garra

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: